Cytosorbents (CTSO) Proxy filing summary

Executive summary

• Annual Meeting scheduled for August 13, 2026, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and annual report for the year ended December 31, 2025, prior to voting.

Voting matters and shareholder proposals

• Election of five director nominees: Phillip P. Chan, Michael G. Bator, Edward R. Jones, Alan D. Sobel, and Jiny Kim.

• Advisory vote on executive compensation for named executive officers.

• Ratification of WithumSmith + Brown, PC as independent auditors for fiscal year ending December 31, 2026.

• Approval of a reverse stock split at a ratio between 1-for-5 and 1-for-20, at the Board's discretion, within one year of approval.

• Approval to adjourn the meeting if necessary to solicit additional votes.

• Provision to conduct other business as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and all proposals.